Rico, Samara Rodrigues Alves; Abbasi, Azhar Z; Ribeiro, Geise; Ahmed, Taksim; Wu, Xiao Yu; Silva, Denise de Oliveira 
Source: Nanoscale. Unidade: IQ
Subjects: NANOPARTÍCULAS, NEOPLASIAS PROSTÁTICAS, NEOPLASIAS MAMÁRIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RICO, Samara Rodrigues Alves et al. Diruthenium(II,III) metallodrugs of ibuprofen and naproxen encapsulated in intravenously injectable polymer-lipid nanoparticles exhibit enhanced activity against breast and prostate cancer cells. Nanoscale, v. 9, n. 30, p. 10701-10714, 2017Tradução . . Disponível em: https://doi.org/10.1039/c7nr01582h. Acesso em: 03 jun. 2024.APA
Rico, S. R. A., Abbasi, A. Z., Ribeiro, G., Ahmed, T., Wu, X. Y., & Silva, D. de O. (2017). Diruthenium(II,III) metallodrugs of ibuprofen and naproxen encapsulated in intravenously injectable polymer-lipid nanoparticles exhibit enhanced activity against breast and prostate cancer cells. Nanoscale, 9( 30), 10701-10714. doi:10.1039/c7nr01582hNLM
Rico SRA, Abbasi AZ, Ribeiro G, Ahmed T, Wu XY, Silva D de O. Diruthenium(II,III) metallodrugs of ibuprofen and naproxen encapsulated in intravenously injectable polymer-lipid nanoparticles exhibit enhanced activity against breast and prostate cancer cells [Internet]. Nanoscale. 2017 ; 9( 30): 10701-10714.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1039/c7nr01582hVancouver
Rico SRA, Abbasi AZ, Ribeiro G, Ahmed T, Wu XY, Silva D de O. Diruthenium(II,III) metallodrugs of ibuprofen and naproxen encapsulated in intravenously injectable polymer-lipid nanoparticles exhibit enhanced activity against breast and prostate cancer cells [Internet]. Nanoscale. 2017 ; 9( 30): 10701-10714.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1039/c7nr01582h
